Literature DB >> 31844143

Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.

Ryan C Stoner1, Richard D Press2,3, Julia E Maxson1,3, Jeffrey W Tyner3,4,5, Kim-Hien T Dao6,7.   

Abstract

Entities:  

Year:  2019        PMID： 31844143     DOI： 10.1038/s41375-019-0688-1

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Understanding Drug Sensitivity and Tackling Resistance in Cancer.

Authors:  Jeffrey W Tyner; Franziska Haderk; Anbarasu Kumaraswamy; Linda B Baughn; Brian Van Ness; Song Liu; Himangi Marathe; Joshi J Alumkal; Trever G Bivona; Keith Syson Chan; Brian J Druker; Alan D Hutson; Peter S Nelson; Charles L Sawyers; Christopher D Willey
Journal:  Cancer Res       Date:  2022-04-15       Impact factor: 13.312

2.  Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.

Authors:  Franziska C Adam; Jakub Szybinski; Jörg P Halter; Nathan Cantoni; Friedel Wenzel; Katharina Leonards; Sime Brkic; Jakob R Passweg; Ivo Touw; Julia E Maxson; Sara C Meyer
Journal:  Curr Oncol       Date:  2022-02-01       Impact factor: 3.109

3.  Rare evolution of CSF3R-mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with SETBP1 mutation.

Authors:  Maki Hirao; Kentaro Watanabe; Yuiko Tsukada; Hisako Kunieda; Makoto Osada; Kohei Yamazaki; Ryunosuke Denda; Shinichiro Okamoto; Takahide Kikuchi
Journal:  Leuk Res Rep       Date:  2022-04-12

Review 4.  Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management.

Authors:  Thomas P Thomopoulos; Argiris Symeonidis; Alexandra Kourakli; Sotirios G Papageorgiou; Vasiliki Pappa
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 5.  Current Management of Chronic Neutrophilic Leukemia.

Authors:  Natasha Szuber; Ayalew Tefferi
Journal:  Curr Treat Options Oncol       Date:  2021-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.